ESC 365 - Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation

HFA Premium Access

Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation

Session: Poster Session 2 - Cardiovascular Surgery - Other

Topic: Cardiovascular Surgery, Other

Speaker: Doctor R. Lopez Vilella (Valencia, ES)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Raquel Lopez Vilella

Hospital Universitario y Politecnico La Fe, Valencia (Spain)

1 presentation

0 follower

4 more presentations in this session

Idarucizumab for urgent dabigatran reversal at the heart transplantation surgery. Multicenter experience from Spain

Speaker: Professor M. Crespo-Leiro (A Coruna, ES)

The influence of LVAD on mitral regurgitation and pulmonary system

Speaker: Mr D. Brenna (Cinisello Balsamo, IT)

Preoperative levosimendan improves outcomes of coronary artery bypass grafting in patients with poor left ventricular function: cardiologist's opinion

concurrent implantation of intra-aortic balloon pumping with extracorporeal membrane oxygenation improved survival of patients with postcardiotomy cardiogenic shock

Speaker: Doctor K. Chen (Beijing, CN)

Access the full session

Poster Session 2 - Cardiovascular Surgery - Other

Speakers: Doctor R. Lopez Vilella, Professor M. Crespo-Leiro, Mr D. Brenna, Doctor K. Chen

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources